SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023183
Filing Date
2016-08-08
Accepted
2016-08-08 11:28:41
Documents
74
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne-10q_20160630.htm 10-Q 1240529
2 EX-10.6 srne-ex106_103.htm EX-10.6 44090
3 EX-10.7 srne-ex107_352.htm EX-10.7 465598
4 EX-31.1 srne-ex311_8.htm EX-31.1 9650
5 EX-31.2 srne-ex312_9.htm EX-31.2 9594
6 EX-32.1 srne-ex321_7.htm EX-32.1 10948
  Complete submission text file 0001564590-16-023183.txt   7317574

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT srne-20160630.xml EX-101.INS 1326658
8 XBRL TAXONOMY EXTENSION SCHEMA srne-20160630.xsd EX-101.SCH 70997
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20160630_cal.xml EX-101.CAL 54876
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20160630_def.xml EX-101.DEF 269145
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20160630_lab.xml EX-101.LAB 514891
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20160630_pre.xml EX-101.PRE 424862
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 161813207
SIC: 8731 Services-Commercial Physical & Biological Research